Fundraising Fox
/Companies
Sign in

AmplifiDx

Pleasanton, US · Founded 2020 · Delaware corporation · 4 known investors

Find your way into AmplifiDx

Sign up to see every warm intro you have to AmplifiDx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AmplifiDx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

AmplifiDx develops point-of-care molecular diagnostic tests and its DX 100 platform for family, women's, and sexual health, targeting infectious disease detection for healthcare professionals and patients. The multiplex platform can detect up to 10 analytes with rapid results and minimal hands-on time.

BiotechDigital HealthFemTechHealthtechMedical Devices

Founders & leadership

NSNancy Schoenbrunner
Nancy SchoenbrunnerChief Executive Officer & Co-FounderNancy Schoenbrunner leads AmplifiDx as Chief Executive Officer. She has worked in medical device and in vitro diagnostics across product development, R&D strategy, and cross-functional team leadership, with academic training across the US, Germany, Switzerland, and the UK.
SDShoulian Dong
Shoulian DongChief Scientific Officer
DSDaniel Schoener
Daniel SchoenerChief Product Officer
CMChris Meda
Chris MedaChief Commercial Officer
MT
Ming TanNamed on SEC filing
SD
Sammy DatwaniNamed on SEC filing
BS
Bruce SargeantNamed on SEC filing

Investors · 4

Beacon Angelslisted by Beacon AngelsBoston · $50K – $400K
Social Startslisted by Social StartsSan Francisco

How we know: Social Starts's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Shepherd VenturesreportedSan Diego · $750K – $3M

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$329.4K disclosed across 1 of 2 rounds · 2021–2024

▶$329.4KraisedJul 2021 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nancy SchoenbrunnerExecutive Officer, Director
  • Ming TanDirector
  • Sammy DatwaniDirector
  • Bruce SargeantDirector
Offering amount
$2.1M
Amount sold
$329.4K
Minimum investment
$1
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Digital DiagnosticsDigital Diagnostics is a healthcare technology company that builds AI systems to diagnose disease by analyzing medical images. Its flagship system diagnoses diabetes-related eye disease at the point of care without requiring a physician to review the images, serving primary and specialty care providers.
CareDxCareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.
Foresight DiagnosticsForesight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types. Its offerings support oncology drug development, clinical trials, and patient care for academic and biopharma partners.
EarlydxEarlyDx develops non-invasive liquid biopsy tests aimed at early cancer detection and precision medicine. The company positions its tests as accurate and affordable diagnostics.
Athenahealth IncCloud-based healthcare platform for clinical workflows

Companies working in the same space as AmplifiDx.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2023$286.8K
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$400K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

AmplifiDx Secures Additional $954,213 in Non-Dilutive Funding from NIH’s RADx Tech Program to Advance U.S. COVID-19 Testing Capabilities. — AmplifiDxamplifidx.com · Dec 2024Press Release - AmplifiDx Secures $1.38 M to Develop Groundbreaking Molecular Point-of-Care System — AmplifiDxamplifidx.com · May 2019

Frequently asked questions

What does AmplifiDx do?
AmplifiDx develops point-of-care molecular diagnostic tests and its DX 100 platform for family, women's, and sexual health, targeting infectious disease detection for healthcare professionals and patients. The multiplex platform can detect up to 10 analytes with rapid results and minimal hands-on time.
Who are AmplifiDx's investors?
AmplifiDx's investors include Avestria Ventures, Beacon Angels, Social Starts, Shepherd Ventures.
How much funding has AmplifiDx raised?
AmplifiDx has disclosed $329.4K raised across 1 of its 2 known rounds.
Where is AmplifiDx headquartered?
AmplifiDx is headquartered in Pleasanton, US.